Isetshenziselwa Amacala Aphezulu Uma Ezinye Izinketho Akufanelekile
I-basal cell carcinoma yindlela ejwayelekile kunazo zonke zomdlavuza wesikhumba emhlabeni jikelele futhi ingenye yezinyathelo zokuphulukisa kakhulu uma uphathwa kuqala. Ukwelashwa okuvamile kuhlanganisa ukukhipha i-electrodesiccation kanye nokukhishwa (cauterizing nokukhipha lesi sifo) kanye nokuhlinzwa kwe-Mohs (inqubo yokuhlinzeka ngokucophelela).
Olunye uhlobo lwezokwelapha, olwaziwa ngokuthi i-Aldara (imiquimod) ukhilimu oluphezulu, lwamukelwa yi-US Food and Drug Administration ngo-2004 ukuphatha nge- basal cell carcinoma (SBCC) ngokuqondile .
Isebenza ngobumnene ukukhipha isilonda futhi ingasetshenziselwa ukwelapha i- actinic keratosis (i-solar keratosis) kanye nemigqomo yesisu .
Izinkomba zokusetshenziswa
I-Aldara cream yiyona kuphela yokwakhiwa kwezinto eziphezulu ezisebenzisela ukwelapha i-SBCC kubantu abadala abanezivikeli zokuzivikela ezivamile. Kunconywa uma ezinye izindlela zokususa zingalungile (njengokuthi kukhona izilonda eziningi ebusweni). I-Aldara ivuselela amasosha omzimba ukukhiqiza uhlobo lweprotheyini, eyaziwa ngokuthi i-interferon-alpha, ukuhlasela ngokuqondile ngqo amaseli omdlavuza .
Ucwaningo lwangaphambi kwemakethe lubonise ukuthi u-Aldara wakwazi ukusula i-SBCC ngamaphesenti angu-75 abantu abaphathwayo beqhathaniswa namaphesenti amabili kuphela eqenjini le-placebo. Kulabo abaphathwa ngempumelelo ne-Aldara, cishe amaphesenti angu-80 ahlala engenawo umdlavuza ngemva kweminyaka emibili.
Ngenkathi ucwaningo luqhubeka, ucwaningo lubonisa ukuthi i-Aldara ingase iphumelele ekwelapheni i- melanoma esanda kuqala (eyaziwa ngokuthi i- melanoma in situ ) uma ezinye izinketho zokuhlinzwa zingatholakali.
Ukucatshangelwa Ukwelashwa
Aldara akufanele bonke abantu. Memezela udokotela wakho uma wenza ezinye izindlela zokwelapha i-SBCC, i-actinic keratosis, ama-warts omzimba, noma yimuphi omunye umzimba wesikhumba. Uma kunjalo, ungase ucelwe ukuba ulinde kuze kube yilapho ukwelashwa kwamanje kuqediwe futhi isikhumba sakho siphululile ngaphambi kokuqala i-Aldara.
I-Aldara ingase ibe nzima nakakhulu izimo zesikhumba ezivuthayo ezifana ne- psoriasis .
Ayaziwa ukuthi i-Aldara ingalimaza yini ingane ekhulelwe ngesikhathi sokukhulelwa noma idluliselwa kumntwana ngokusebenzisa ubisi lwebele. Khuluma nodokotela wakho mayelana nezinzuzo kanye nemiphumela emihle ye-Aldara uma ukhulelwe noma uhlela ukukhulelwa.
Isicelo
I-Aldara isetshenziswa esikhumbeni kuphela futhi akumele isetshenziswe noma eduze, amehlo akho, izindebe, amaconsi noma amanxeba avulekile.
I-Aldara ivame ukusetshenziswa kuphela kanye ngosuku nsuku zonke izinsuku ezinhlanu ngesonto. Kumele kusale esikhumbeni amahora angu-8 noma ubusuku bonke. Ungafaki indawo ephathwayo ngezingubo zokubopha noma ezinye zokugqoka ezivaliwe. Ngemuva kwamahora ayisishiyagalombili, geza isikhumba esithintekile nge-sese emnene namanzi.
Ukwelashwa kufanele kuqhubeke ngamasonto ayisithupha agcwele. Qhubeka ukusebenzisa i-Aldara ngisho noma i- basal cell lesion isiphelile ngaphandle kokuthi utshele ngenye indlela nge-dermatologist yakho.
Imiphumela Yecala Yezidakamizwa
Umphumela ovame kakhulu ohlangothini lwe-Aldara yi-localized reaction reaction eyenziwa cishe ingxenye yesithathu yazo zonke izimo. Izimpawu ze-dermatological zingabandakanya:
- Ukubomvu
- Ukuvuvukala
- I-sore, i-blister, noma isilonda
- Ukuqina noma ukuqina kesikhumba
- Izinguquko kumbala wesikhumba
- Isikhumba sibheka
- Ukuqhaqhazela nokugquma
- Itching kanye / noma ukuvutha
Indawo ephathwayo ingase ibonakale imbi kakhulu ngaphambi kokuba ibe ngcono.
Gwema ukukhanya kwelanga (noma ama-sunlamps) njengoba lokhu kungase kubize izimpawu. Uma ungaphandle, sebenzisa izingubo zokuzivikela noma isigqoko sokumboza indawo ethintekile. Kwezinye izimo, noma yiziphi izinguquko embala wesikhumba noma ukuthungwa kungenzeka kube unomphela.
Ezinye izimo ezimbi ezingase zibe khona zibandakanya ikhanda, ubuhlungu be-back, ama-muscle aches, ukhathala, umkhuhlane, i- lymph nodes , isifo sohudo, kanye nezifo ezifungayo.
Xhumana nodokotela wakho ngokushesha uma unesikhumba esinzima, uma uhlakulela izimpawu ezifana ne-flu, noma uma izilonda ziqala ukuthuthukisa phakathi nesonto lokuqala lokwelapha.
> Umthombo:
> National Cancer Institute: Izikhungo Zikazwelonke Zempilo. "Ukugunyazwa kwe-FDA ye-Imiquimod - Igama lomkhiqizo (ama): Aldara." I-Bethesda, e-Maryland; ibuyekezwe ngo-Julayi 3, 2013.